Omedime

Main information

  • Trade name:
  • Omedime 40 mg Powder for IV Injection/ Infusion
  • Dosage:
  • 40 mg
  • Pharmaceutical form:
  • Powder for IV Injection/Infusion
  • Units in package:
  • 10 mL-capacity USP Type I amber colored glass vial + 10 mL-net content USP Type I clear and colorless glass ampoule for the dilu
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Scott-Edil Pharmacia Limited

Documents

Localization

  • Available in:
  • Omedime 40 mg Powder for IV Injection/Infusion
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-6814-02
  • Authorization date:
  • 24-08-2021
  • Last update:
  • 15-01-2018